跳至主要内容
临床试验/NCT05171491
NCT05171491进行中(未招募)不适用

Clinical Evaluation of LungLB in Subjects Presenting With Indeterminate Pulmonary Nodules

LungLife AI12 个研究点 分布在 1 个国家目标入组 425 人开始时间: 2022年1月26日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
425
试验地点
12
主要终点
Sensitivity and specificity of LungLB test as compared to results from a tissue/FNA biopsy.

研究概览

简要总结

Correlate performance of LungLB Test with outcome of a scheduled biopsy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 18 years old with a CT identified indeterminate pulmonary nodule and scheduled for biopsy, at the time of consent.
  • Planned biopsy nodule of interest:
  • is solid ≤3 cm; or
  • is nonsolid, ground glass opacity, of any size; or
  • is part solid, where the solid component is no larger than 3cm (maximum diameter).

排除标准

  • Current and or prior diagnosis +/- treatment of non-lung cancer within the past 3 years.
  • Current and or prior lung cancer diagnosis within 2 years following intent-to-cure surgery.

结局指标

主要结局

Sensitivity and specificity of LungLB test as compared to results from a tissue/FNA biopsy.

时间窗: up to 60 days

次要结局

  • Evaluate Clinical Variables With and Without LungLB Test Results(up to 60 days)

研究者

发起方
LungLife AI
申办方类型
Industry
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验